ESC Premium Access

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

Congress Presentation

About the speaker

Doctor Giuseppe Vergaro

Sant'Anna School of Advanced Studies, Pisa (Italy)
8 presentations
0 follower

4 more presentations in this session

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

Speaker: Doctor S. Kiddle (Cambridge, GB)

Thumbnail

Cysteine-rich angiogenic inducer 61 (CCN1) independently predicts all-cause mortality in patients with dilated cardiomyopathy

Speaker: Doctor R. Klingenberg (Bad Nauheim, DE)

Thumbnail

Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure

Speaker: Doctor G. Vergaro (Pisa, IT)

Thumbnail

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

Speaker: Doctor A. Reese-Petersen (Copenhagen, DK)

Thumbnail

Access the full session

Biomarkers to improve prognostication in heart failure: what's new?

Speakers: Doctor G. Vergaro, Doctor S. Kiddle, Doctor R. Klingenberg, Doctor G. Vergaro, Doctor A. Reese-Petersen
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

ESC 365 is supported by